Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and delirium

被引:53
作者
Erstad, Brian L. [1 ]
Barletta, Jeffrey F. [2 ]
机构
[1] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, 1295 N Martin Ave,POB 210202, Tucson, AZ 85721 USA
[2] Midwestern Univ, Coll Pharm, Dept Pharm Practice, 19555 N 59th Ave, Glendale, AZ 85308 USA
来源
CRITICAL CARE | 2020年 / 24卷 / 01期
关键词
Critical illness; Obesity; Pharmacokinetics; Drug-dosing; RAPID-SEQUENCE INTUBATION; POPULATION PHARMACOKINETICS; BODY-WEIGHT; DOSE REQUIREMENTS; MORBID-OBESITY; PROPOFOL; PHARMACODYNAMICS; DEXMEDETOMIDINE; ETOMIDATE; INDUCTION;
D O I
10.1186/s13054-020-03040-z
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Practice guidelines provide clear evidence-based recommendations for the use of drug therapy to manage pain, agitation, and delirium associated with critical illness. Dosing recommendations however are often based on strategies used in patients with normal body habitus. Recommendations specific to critically ill patients with extreme obesity are lacking. Nonetheless, clinicians must craft dosing regimens for this population. This paper is intended to help clinicians design initial dosing regimens for medications commonly used in the management of pain, agitation, and delirium in critically ill patients with extreme obesity. A detailed literature search was conducted with an emphasis on obesity, pharmacokinetics, and dosing. Relevant manuscripts were reviewed and strategies for dosing are provided.
引用
收藏
页数:8
相关论文
共 69 条
[11]   Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model [J].
Cortinez, L. I. ;
Anderson, B. J. ;
Penna, A. ;
Olivares, L. ;
Munoz, H. R. ;
Holford, N. H. G. ;
Struys, M. M. R. F. ;
Sepulveda, P. .
BRITISH JOURNAL OF ANAESTHESIA, 2010, 105 (04) :448-456
[12]   Dexmedetomidine pharmacokinetics in the obese [J].
Cortinez, Luis I. ;
Anderson, Brian J. ;
Holford, Nick H. G. ;
Puga, Valentina ;
de la Fuente, Natalia ;
Auad, Hernan ;
Solari, Sandra ;
Allende, Fidel A. ;
Ibacache, Mauricio .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (12) :1501-1508
[13]   Opioids for Acute Pain Management in Patients With Obstructive Sleep Apnea: A Systematic Review [J].
Cozowicz, Crispiana ;
Chung, Frances ;
Doufas, Anthony G. ;
Nagappa, Mahesh ;
Memtsoudis, Stavros G. .
ANESTHESIA AND ANALGESIA, 2018, 127 (04) :988-1001
[14]   Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide [J].
de Hoogd, Sjoerd ;
Valitalo, Pyry A. J. ;
Dahan, Albert ;
van Kralingen, Simone ;
Coughtrie, Michael M. W. ;
van Dongen, Eric P. A. ;
van Ramshorst, Bert ;
Knibbe, Catherijne A. J. .
CLINICAL PHARMACOKINETICS, 2017, 56 (12) :1577-1587
[15]   Clinical pharmacokinetics of quetiapine - An atypical antipsychotic [J].
DeVane, CL ;
Nemeroff, CB .
CLINICAL PHARMACOKINETICS, 2001, 40 (07) :509-522
[16]  
Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299
[17]   Taming the Ketamine Tiger [J].
Domino, Edward F. .
ANESTHESIOLOGY, 2010, 113 (03) :678-684
[18]   Morbid Obesity Alters Both Pharmacokinetics and Pharmacodynamics of Propofol: Dosing Recommendation for Anesthesia Induction [J].
Dong, Dong ;
Peng, Xuemei ;
Liu, Jie ;
Qian, Hao ;
Li, Jiayang ;
Wu, Baojian .
DRUG METABOLISM AND DISPOSITION, 2016, 44 (10) :1579-1583
[19]   Availability of information for dosing commonly used medications in special ICU populations [J].
Eastman, Candice ;
Erstad, Brian L. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2020, 77 (07) :529-534
[20]   Remifentanil pharmacokinetics in obese versus lean patients [J].
Egan, TD ;
Huizinga, B ;
Gupta, SK ;
Jaarsma, RL ;
Sperry, RJ ;
Yee, JB ;
Muir, KT .
ANESTHESIOLOGY, 1998, 89 (03) :562-573